论文部分内容阅读
Fisons 的平喘抗炎药奈多罗米钠(ne-docromilsodium,商品名 Tilade(在等候了5年之后获得美国 FDA 的批准。该产品到1993年第二季度才有望上市,并将和 RhonePoulenc Rorer 公司合作促销。奈多罗米钠的适应症为有12年以上轻至
Fisons anti-asthma anti-inflammatory drug nedocromilyl sodium (trade name Tilade (waited five years after the US FDA approval of the product is expected to be listed in the second quarter of 1993, and RhonePoulencRorer company Cooperation and promotion .Nedoterol sodium indications for more than 12 years to light